Waiting list mortality among children listed for heart transplantation in the United States

Circulation

Volumn 119, Issue 5, 2009, Pages 717-727

  Almond, Christopher S D ^a,b   Thiagarajan, Ravi R ^a   Piercey, Gary E ^a   Gauvreau, Kimberlee ^a,c,d   Blume, Elizabeth D ^a,b   Bastardi, Heather J ^a,b   Fynn Thompson, Francis ^a,b   Singh, T P ^a,b  

^a Department of Cardiology ^*

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Heart failure; Heart assist devices; Pediatrics; Survival; Transplantation, heart

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; BODY WEIGHT; CHILD; CHILDHOOD MORTALITY; CONGENITAL HEART DISEASE; DIALYSIS; ETHNIC DIFFERENCE; EXTRACORPOREAL OXYGENATION; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; REGISTER; RISK ASSESSMENT; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES; ADOLESCENT; CLINICAL TRIAL; COHORT ANALYSIS; HEART ASSIST DEVICE; HEART FAILURE; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREDICTION AND FORECASTING; RESOURCE ALLOCATION; RISK FACTOR; STATISTICS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; REGISTRIES; RESOURCE ALLOCATION; RESPIRATION, ARTIFICIAL; RISK FACTORS; UNITED STATES; WAITING LISTS;

EID: 61549112147     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.815712     Document Type: Article

References (36)

1. McDiarmid S. Death on the pediatric waiting list: scope of the problem. Paper presented at: Summit on Organ Donation and Transplantation; March 2007; San Antonio, Tex.
2. Renlund DG, Taylor DO, Kfoury AG, Shaddy RS. New UNOS rules: historical background and implications for transplantation management: United Network for Organ Sharing. J Heart Lung Transplant. 1999;18: 1065-1070.
3. West LJ, Pollock-Barziv SM, Dipchand AI, Lee KJ, Cardella CJ, Benson LN, Rebeyka IM, Coles JG. ABO-incompatible heart transplantation in infants. N Engl J Med. 2001;344:793-800.
4. West LJ, Karamlou T, Dipchand AI, Pollock-BarZiv SM, Coles JG, McCrindle BW. Impact on outcomes after listing and transplantation, of a strategy to accept ABO blood group-incompatible donor hearts for neonates and infants. J Thorac Cardiovasc Surg. 2006;131:455-461.
5. Addonizio LJ, Naftel D, Pricker J, Morrow WR, Kirklin JK, McGiffin DC, Dodd D, Bernstein D. Risk factors for pretransplant outcome in children listed for cardiac transplantation: a multi-institutional study. J Heart Lung Transplant. 1995;14:S48. Abstract.
6. McGiffin DC, Naftel DC, Kirklin JK, Morrow WR, Towbin J, Shaddy R, Alejos J, Rossi A; Pediatric Heart Transplant Study Group. Predicting outcome after listing for heart transplantation in children: comparison of Kaplan-Meier and parametric competing risk analysis. J Heart Lung Transplant. 1997;16:713-722.
7. Morrow WR, Naftel D, Chinnock R, Canter C, Boucek M, Zales V. McGiffin DC, Kirklin JK; Pediatric Heart Transplantation Study Group. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. J Heart Lung Transplant. 1997;16:1255-1266.
8. Morrow WR, Frazier E, Naftel DC. Survival after listing for cardiac transplantation in children. Prog Pediatr Cardiol. 2000;11:99-105.
9. Nield LE, McCrindle BW, Bohn DJ, West LJ, Coles JG, Freedom RM, Benson LN. Outcomes for children with cardiomyopathy awaiting transplantation. Cardiol Young. 2000;10:358-366.
10. Mital S, Addonizio LJ, Lamour JM, Hsu DT. Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation. J Heart Lung Transplant. 2003;22:147-153.
11. Feingold B, Bowman P, Zeevi A, Girnita AL, Quivers ES, Miller SA, Webber SA. Survival in allosensitized children after listing for cardiac transplantation. J Heart Lung Transplant. 2007;26:565-571.
12. Pollock-BarZiv SM, McCrindle BW, West LJ, Manlhiot C, VanderVliet M, Dipchand AI. Competing outcomes after neonatal and infant wait-listing for heart transplantation. J Heart Lung Transplant. 2007;26: 980-985.
13. Chen JM, Weinberg AD, Rose EA, Thompson SM, Mancini DM, Ellison JP, Reemtsma K, Michler RE. Multivariate analysis of factors affecting waiting time to heart transplantation. Ann Thorac Surg. 1996;61: 570-575.
14. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58:259-263.
15. 63 Federal Register 16295, at 16332 (1998) (codified at 42 CFR part 121).
16. Conrad SA, Rycus PT, Dalton H. Extracorporeal Life Support Registry Report 2004. ASAIO J. 2005;51:4-10.
17. Canter CE, Shaddy RE, Bernstein D, Hsu DT, Chrisant MR, Kirklin JK, Kanter KR, Higgins RS, Blume ED, Rosenthal DN, Boucek MM, Uzark KC, Friedman AH, Young JK. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;115: 658-676.
18. Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality? Arch Surg. 2007;142:1079-1085.
19. Egan TM, Kotloff RM. Pro/con debate: lung allocation should be based on medical urgency and transplant survival and not on waiting time. Chest. 2005;128:407-415.
20. Freeman RB Jr, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl. 2000;6:543-552.
21. Levine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, Schaubel DE. Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant. 2006;6:1228-1242.
22. Rosen HR, Prieto M, Casanovas-Taltavull T, Cuervas-Mons V, Guckelberger O, Muiesan P, Strong RW, Bechstein WO, O'Grady J, Zaman A, Chan B, Berenguer J, Williams R, Heaton N, Neuhaus P. Validation and refinement of survival models for liver retransplantation. Hepatology. 2003; 38:460-469.
23. Travaline JM, Cordova FC, Furukawa S, Criner GJ. Discrepancy between severity of lung impairment and seniority on the lung transplantation list. Transplant Proc. 2004;36:3156-3160.
24. Boucek MM, Aurora P, Edwards LB, Taylor DO, Trulock EP, Christie J, Dobbels F, Rahmel AO, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report: 2007. J Heart Lung Transplant. 2007;26: 796-807.
25. Davies RR, Russo MJ, Mital S, Martens TM, Sorabella RS, Hong KN, Gelijns AC, Moskowitz AJ, Quaegebeur JM, Mosca RS, Chen JM. Predicting survival among high-risk pediatrie cardiac transplant recipients: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg. 2008;135:147-155.
26. Duncan BW. Pediatric mechanical circulatory support in the United States: past, present, and future. ASAIO J. 2006;52:525-529.
27. Baldwin JT, Borovetz HS, Duncan BW, Gartner MJ, Jarvik RK, Weiss WJ, Hoke TR. The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program. Circulation. 2006;113:147-155.
28. Almond CS, Chen EA, Berman MR, Less JR, Baldwin JT, Linde-Feucht SR, Hoke TR, Pearson GD, Jenkins K, Duncan BW, Zuckerman BD. High-risk medical devices, children and the PDA: regulatory challenges facing pediatric mechanical circulatory support devices. ASAIO J. 2007; 53:4-7.
29. Rinaldi JE, Chen EA, Berman MR. Pediatric circulatory support: an FDA perspective. ASAIO J. 2005;51:533-535.
30. Organ Donation Breakthrough Collaborative. About the collaborative, Available at: www.organdonationnow.org. Accessed November I, 2008.
31. Blume ED, Naftel DC, Bastardi HJ, Duncan BW, Kirklin JK, Webber SA. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation. 2006;113: 2313-2319.
32. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, Poirier VL, Dasse KA. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122: 1186-1195.
33. Hill JD, Reinhartz O. Clinical outcomes in pediatric patients implanted with Thoratec ventricular assist device. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006:115-122.
34. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896.
35. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005. J Am Coll Cardiol. 2007;50:1282-1290.
36. Boucek MM, Mashburn C, Dunn SM, Frizell R, Edwards L, Pietra B, Campbell D. Pediatric heart transplantation after declaration of cardio-circulatory death. N Engl J Med. 2008;359:709-714.